Biosite Diagnostics Inc., Medarex, Eli Lilly deal

BSTE and MEDX will use their co-developedTrans-Phage Technology to generate human antibodies to

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE